Medical News

RSS

Capsule launches first intelligent touch-screen platform to manage bedside device connectivity

Capsule, the leading provider of medical device connectivity, today announced its official release of the Capsule Neuron™. Following Capsule's recent release of their Enterprise Device Connectivity Solution, the flexible, innovative Capsule Neuron platform allows the solution to be deployed across the hospital in both high and low acuity environments.

2 Dec 2009

Accera Pharmaceuticals to implement the Veeva CRM suite of multi-tenant SaaS applications

Less than 9 months after implementing a new CRM application, Accera Pharmaceuticals began searching for a replacement. The commercial-stage biotechnology company, which launched Axona™ (a prescription-only medical food for the clinical dietary management of the metabolic processes associated with mild-to-moderate Alzheimer's disease) around the same time as it implemented its current system, had quickly outgrown the generic CRM tool.

2 Dec 2009

S*BIO to present data on its novel oral JAK2 inhibitor at The American Society of Hematology meeting

S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans.

2 Dec 2009

Sepracor to present clinical study data of STEDESA at the 2009 AES meeting

Sepracor Inc. today announced that clinical study data for STEDESA™ (eslicarbazepine acetate) will be presented at the 2009 annual meeting of the American Epilepsy Society (AES) in Boston. Seven posters describing new safety analyses will be presented at the Hynes Convention Center during the formal poster session on Saturday, December 5, 2009 between 1:00 pm and 8:00 pm EST.

2 Dec 2009

Positive results from DermaGen's Phase I/IIa AMP study of atopic dermatitis

DermaGen AB - part of the Karolinska Development dermatology and wound healing company "Pergamum" - announced that Dermagen AB has received promising results from a clinical Phase I/IIa study. DermaGen AB is developing a novel antimicrobial peptide (AMP) treatment for atopic dermatitis. Atopic dermatitis is a chronic inflammatory skin disease where dry skin and the skin's weakened barrier function make patients susceptible to colonization by microorganisms, a triggering or exacerbating factor of the disease.

2 Dec 2009

NHLBI awards stimulus funds for hemophilia drug research

PTC Therapeutics, Inc. (PTC) today announced the receipt of a $1 million Challenge Grant award from the National Heart, Lung, and Blood Institute (NHLBI) as part of the National Institutes of Health (NIH).

2 Dec 2009

IDN Health Systems implements PHACTS' Enterprise-Wide Inventory Management Solution

PHACTS, LLC, a leader in Pharmacy Inventory Management Systems, signed exclusive agreements in 2009 with USA IDN Health Systems and hospitals valued at $22.4 million in new business. PHACTS expects this number to grow to over $30 million by the end of 2009.

2 Dec 2009

International AIDS Vaccine Initiative calls for redoubled efforts in vaccine development

As we approach World AIDS Day, observed globally December 1, we are reminded that while progress has been made in expanding access to treatment and prevention and that progress has been made toward the development of new prevention tools, the world is still falling short of established targets for providing universal access to HIV and AIDS prevention, treatment and care by 2010. Nearly 5.5 million of the estimated 9.5 million people in need of antiretroviral therapy are still not receiving it.

2 Dec 2009

Protein marker may hold the key against pancreatic cancer

Pancreatic tumors can be identified by a readily detectable marker that shows promise as a basis for immune therapy against the disease, according to research at Washington University School of Medicine in St. Louis.

2 Dec 2009

Worldwide DRTV marketing of BioElectronics' ActiPatch and Allay brands

BioElectronics Corp., the maker of inexpensive, disposable drug-free anti-inflammatory devices, today announced the details of its worldwide Direct Response Television (DRTV) strategy to further enhance its international marketing efforts for its award-winning, pain relieving ActiPatch and Allay brands. The Company will launch campaigns in Latin America beginning in December, Canada in January, Europe and Australia in the first quarter and is currently in process of negotiating a partnership to enter the lucrative Japanese market.

2 Dec 2009

BC's Ministry of Health cuts funds for HIV and AIDS service organizations

Today, as local and national governments around the world reaffirm their commitment to continue the fight against HIV and AIDS, BC's government is doing the opposite.

2 Dec 2009

Coding guidelines for Agendia's MammaPrint test established by Palmetto GBA

Agendia, a world leader in molecular cancer diagnostics, announced today that Palmetto GBA, California's Part B Medicare administrator, has established coding guidelines for the company's MammaPrint test.

2 Dec 2009

Columbia University VP testifies on medical malpractice reform

Lee Goldman, M.D., executive vice president for health and biomedical sciences and dean of the faculties of medicine and health sciences at Columbia University testified today on medical malpractice reform before the New York State Senate Committees on Codes, Health and Insurance in Albany, New York.

2 Dec 2009

Statistics of HIV/AIDS cases in the U.S. population

On December 31, 2008, a reported 20,606 state prisoners and 1,538 federal prisoners were HIV positive or had confirmed AIDS, the Bureau of Justice Statistics (BJS) in the Office of Justice Programs, U.S. Department of Justice, announced today.

2 Dec 2009

Health eTouch helps to enhance communications between patients and doctors

Parents of teens know just how difficult it is to get them to talk about their personal lives, let alone their health. With only 20 percent of children with mental health problems in the United States being properly identified and treated, it is imperative that a solution be found. Doctors and researchers at Nationwide Children's Hospital are one step closer by finding a new way to get teens to open up about their health and what's really on their mind, bringing up issues that otherwise would have gone unnoticed.

2 Dec 2009

First Edition: December 2, 2009

Today's headlines detail the Senate's effort to confront contentious amendments and partisan strife on day two of that chamber's health reform debate.

2 Dec 2009

Kaiser workers face pay and healthcare benefits risk by NLRB decision

A decision issued today by a regional director of the National Labor Relations Board (NLRB) has put at risk the guaranteed raises, healthcare coverage, and pensions of Kaiser Permanente RNs, social workers, and professionals in Southern California.

2 Dec 2009

AFA to host a webinar on Catholics and IVF

On Monday, The American Fertility Association will host a webinar entitled Catholics and IVF: A Pastoral Approach, presented by Father Jon Pedigo. IVF, or In Vitro Fertilization, is a form of assisted reproductive technology (ART) often used by couples and individuals who are having difficulty conceiving a child naturally. During the IVF process, one or more embryos are implanted into a woman's uterus and the remaining, unused embryos are destroyed, frozen, or donated.

2 Dec 2009

A leader in the fight against brain diseases and in drug discovery joins UF

A leader in the fight against brain diseases and in drug discovery to help Alzheimer's patients has joined the University of Florida College of Medicine, interim dean Michael Good, M.D., announced.

2 Dec 2009

FDA approves additional intended use of Roche's cobas TaqScreen MPX Test

Roche announced today that the United States Food & Drug Administration (FDA) approved an additional intended use for its licensed nucleic acid test, to screen source plasma in pools comprised of up to 96 individual donations. The test, called the cobas® TaqScreen MPX Test for use on the cobas s 201 system, is a qualitative, in-vitro test for the simultaneous, direct detection of the human immunodeficiency virus (HIV-1 Group M RNA, HIV-1 Group O RNA , HIV-2 RNA), hepatitis C virus RNA and hepatitis B virus DNA in human plasma.

From Roche Sequencing and Life Science 2 Dec 2009